Table 3. Levels of IL-17 in CSF from patients with different clinical states of syphilis.
| Detection rate of IL-17(%) | IL-17(pg/ml) | |||
| p a | p b | |||
| Control | 0(0/29) | 0 | — | — |
| Non-neurosyphilis | 11.6(8/69) | 0(0–2.60) | — | — |
| Asymptomatic | 47.5(19/40) | 0.715(0–44.27)a | p = 0.000 | — |
| Meningovascular | 25(1/4) | 0(0–8.93) | p = 0.340 | p = 0.608 |
| Paretic | 76.9(30/39) | 7.6(0–38.07)ab | p = 0.000 | p = 0.000 |
| Tabetic | 50(4/8) | 0.78(0–18.23)a | p = 0.002 | p = 0.571 |
| Ocular | 50(6/12) | 0.92(0–59.83)a | p = 0.000 | p = 0.640 |
Data are given as median (range), or frequencies,
a
v.s. syphilis patients without neurological involvement.
b
v.s. asymptomatic neurosyphilis patients.
IL-17 levels represent the median (range).